HALEON UK HOLDINGS (NO.3) LIMITED
Company Documents
| Date | Description |
|---|---|
| 25/06/2525 June 2025 | |
| 25/06/2525 June 2025 | |
| 25/06/2525 June 2025 | Audit exemption subsidiary accounts made up to 2024-12-31 |
| 25/06/2525 June 2025 | |
| 08/05/258 May 2025 | Confirmation statement made on 2025-05-08 with no updates |
| 26/02/2526 February 2025 | Resolutions |
| 26/02/2526 February 2025 | Memorandum and Articles of Association |
| 23/09/2423 September 2024 | Termination of appointment of Thomas Whittle as a director on 2024-09-20 |
| 21/08/2421 August 2024 | |
| 21/08/2421 August 2024 | Audit exemption subsidiary accounts made up to 2023-12-31 |
| 21/08/2421 August 2024 | |
| 21/08/2421 August 2024 | |
| 13/05/2413 May 2024 | Confirmation statement made on 2024-05-13 with updates |
| 20/10/2320 October 2023 | Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 2023-10-20 |
| 17/10/2317 October 2023 | Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 2022-07-19 |
| 22/09/2322 September 2023 | Full accounts made up to 2022-12-31 |
| 18/08/2318 August 2023 | Certificate of change of name |
| 05/06/235 June 2023 | Director's details changed for Haleon Uk Corporate Secretary Limited on 2022-07-18 |
| 05/06/235 June 2023 | Director's details changed for Haleon Uk Corporate Director Limited on 2022-07-18 |
| 31/05/2331 May 2023 | Appointment of Mr Thomas Whittle as a director on 2023-05-11 |
| 23/05/2323 May 2023 | Confirmation statement made on 2023-05-15 with updates |
| 17/05/2317 May 2023 | Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 2023-03-31 |
| 17/05/2317 May 2023 | Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 2023-03-31 |
| 28/04/2328 April 2023 | Termination of appointment of David Christopher Senior as a director on 2023-04-14 |
| 03/10/223 October 2022 | Full accounts made up to 2021-12-31 |
| 06/04/226 April 2022 | Termination of appointment of the Wellcome Foundation Limited as a director on 2022-04-06 |
| 06/04/226 April 2022 | Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 2022-04-06 |
| 06/04/226 April 2022 | Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 2022-04-06 |
| 06/04/226 April 2022 | Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 2022-04-06 |
| 31/12/2131 December 2021 | Cessation of Gsk Consumer Healthcare Holdings (No.5) Limited as a person with significant control on 2021-11-22 |
| 31/12/2131 December 2021 | Cessation of Gsk Consumer Healthcare Holdings (No.7) Limited as a person with significant control on 2021-11-22 |
| 31/12/2131 December 2021 | Cessation of Consumer Healthcare Holdings Limited as a person with significant control on 2021-11-22 |
| 31/12/2131 December 2021 | Notification of Consumer Healthcare Intermediate Holdings Limited as a person with significant control on 2021-11-22 |
| 31/12/2131 December 2021 | Cessation of Consumer Healthcare Intermediate Holdings Limited as a person with significant control on 2021-11-22 |
| 31/12/2131 December 2021 | Notification of Consumer Healthcare Holdings Limited as a person with significant control on 2021-11-22 |
| 31/12/2131 December 2021 | Notification of Glaxosmithkline Consumer Healthcare Holdings (No.2) Limited as a person with significant control on 2021-11-22 |
| 31/12/2131 December 2021 | Notification of Gsk Consumer Healthcare Holdings (No.7) Limited as a person with significant control on 2021-11-22 |
| 19/11/2119 November 2021 | Statement of capital on 2021-11-19 |
| 19/11/2119 November 2021 | |
| 19/11/2119 November 2021 | Resolutions |
| 19/11/2119 November 2021 | Resolutions |
| 19/11/2119 November 2021 | Resolutions |
| 19/11/2119 November 2021 | |
| 11/11/2111 November 2021 | Second filing of a statement of capital following an allotment of shares on 2021-09-01 |
| 19/10/2119 October 2021 | Memorandum and Articles of Association |
| 11/10/2111 October 2021 | Statement of capital following an allotment of shares on 2021-09-01 |
| 10/08/2110 August 2021 | Cessation of Prism Pch Limited as a person with significant control on 2021-06-28 |
| 10/08/2110 August 2021 | Notification of Gsk Consumer Healthcare Holdings (No.5) Limited as a person with significant control on 2021-06-28 |
| 15/06/2115 June 2021 | Current accounting period shortened from 2022-05-31 to 2021-12-31 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company